Mutant endoglycoceramidases with enhanced synthetic activity
OwnerKarl F. Johnson, Shawn DeFrees +2inventors
InventorsKarl F. Johnson, Shawn DeFrees, Stephen Withers, Mark Vaughan
Life of this patent
Estimating the term…
Loading patent…
OwnerKarl F. Johnson, Shawn DeFrees +2inventors
InventorsKarl F. Johnson, Shawn DeFrees, Stephen Withers, Mark Vaughan
Estimating the term…
The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mutant version of a naturally occurring endoglycoceramidase, preferably comprising a mutation within the active site or the nucleophilic site of the enzyme and more preferably comprising a substitution mutation of the Glu residue within the active site or the nucleophilic site. Also disclosed are a method for generating the mutant endoglycoceramidase and a method for enzymatically synthesizing glycolipids using this mutant enzyme.
(canceled)
A mutant endoglycoceramidase, wherein the mutant endoglycoceramidase comprises a wild-type endoglycoceramidase peptide sequence including a nucleophilic region as set forth in SEQ ID NO:
Dependencies are inferred from the claim text.